{"id":"NCT00843492","sponsor":"GlaxoSmithKline","briefTitle":"A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery","officialTitle":"A Multicentre, Randomized, Open-label Study to Evaluate the Efficacy andSafety of Fondaparinux Versus Low Molecular Weight Heparin(Nadroparin) in Patients Requiring Rigid or Semi-rigid Immobilization for at Least 21 Days and up to 45 Days Because of Isolated Non-surgical Below-Knee Injury","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12","primaryCompletion":"2010-01","completion":"2010-06","firstPosted":"2009-02-13","resultsPosted":"2012-07-18","lastUpdate":"2016-03-16"},"enrollment":1351,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Thrombosis, Venous"],"interventions":[{"type":"DRUG","name":"Fondaparinux sodium","otherNames":[]},{"type":"DRUG","name":"Nadroparin","otherNames":[]}],"arms":[{"label":"Nadroparin","type":"ACTIVE_COMPARATOR"},{"label":"Fondaparinux","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of fondaparinux in comparison with a heparin (nadroparin) in preventing deep vein thrombosis (blood clots in the leg veins), whether symptomatic or detected by ultrasound, and pulmonary embolism (blood clots that migrate to the lungs) in patients with leg injuries below the knee that require a cast or other type of immobilization but not surgery.","primaryOutcome":{"measure":"Number of Participants With Venous Thromboembolism (VTE) or Death up to the Time of Complete Mobilization","timeFrame":"Day 1 to complete mobilization plus 2 days (average of 35.9 study days)","effectByArm":[{"arm":"Nadroparin","deltaMin":48,"sd":null},{"arm":"Fondaparinux","deltaMin":15,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":28},"locations":{"siteCount":122,"countries":["France","Germany","Italy","Netherlands","Russia","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":670},"commonTop":["Headache","Injection site haematoma","Pain in extremity","Nausea","Arthralgia"]}}